Related Experiment Video
Updated: Mar 8, 2026

Protein Misfolding Cyclic Amplification of Prions
Published on: November 7, 2012
Novel strain properties distinguishing sporadic prion diseases sharing prion protein genotype and prion type
Laura Cracco1, Silvio Notari1, Ignazio Cali1
1Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.
Abstract:
In most human sporadic prion diseases the phenotype is consistently associated with specific pairings of the genotype at codon 129 of the prion protein gene and conformational properties of the scrapie PrP (PrPSc) grossly identified types 1 and 2. This association suggests that the 129 genotype favours the selection of a distinct strain that in turn determines the phenotype. However, this mechanism cannot play a role in the phenotype determination of sporadic fatal insomnia (sFI) and a subtype of sporadic Creutzfeldt-Jakob disease (sCJD) identified as sCJDMM2, which share 129 MM genotype and PrPSc type 2 but are associated with quite distinct phenotypes. Our detailed comparative study of the PrPSc conformers has revealed major differences between the two diseases, which preferentially involve the PrPSc component that is sensitive to digestion with proteases (senPrPSc) and to a lesser extent the resistant component (resPrPSc). We conclude that these variations are consistent with two distinct strains in sFI and sCJDMM2, and that the rarer sFI is the result of a variant strain selection pathway that might be favoured by a different brain site of initial PrPSc formation in the two diseases.
Insights
Distinct prion strains cause sporadic fatal insomnia and CJD, differing in protease-sensitive PrPSc. This suggests a new pathway for prion disease phenotype determination, potentially influenced by initial prion formation site.
Area of Science:
- Neuroscience
- Prion Biology
- Molecular Biology
Background:
- Sporadic prion diseases often link phenotype to prion protein gene (PRNP) codon 129 genotype and PrPSc types.
- This model doesn't explain distinct phenotypes in sFI and sCJDMM2 despite shared MM genotype and PrPSc type 2.
Purpose of the Study:
- To investigate the molecular basis for differing phenotypes in sFI and sCJDMM2.
- To compare PrPSc conformers in sFI and sCJDMM2 to identify strain-specific characteristics.
Main Methods:
- Comparative analysis of PrPSc conformers from sFI and sCJDMM2 patients.
- Detailed characterization of protease-sensitive (senPrPSc) and protease-resistant (resPrPSc) components.
Main Results:
- Significant differences were found in PrPSc conformers between sFI and sCJDMM2.
- Variations were more pronounced in the senPrPSc component than in resPrPSc.
- These differences support the existence of distinct prion strains for sFI and sCJDMM2.
Conclusions:
- sFI and sCJDMM2 represent distinct prion strains.
- The unique phenotype of sFI may arise from a variant strain selection pathway.
- Initial prion formation site could influence strain selection and disease phenotype.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Subviral Agents

